Inactive Instrument

All News Big Cypress Acquisition Corp. Nasdaq

Equities

BCYPU

US0891152086

All News

Unlock all the news: Be the first to know and act before the market!

UNAUDITED PRO FORMA COMBINED CONDENSED CONSOLIDATED FINANCIAL INFORMATION - Form 8-K	21-10-28	PU
Big Cypress Acquisition Corp.(NasdaqCM:BCYP) dropped from NASDAQ Composite Index	21-10-22	CI
SAB Biotherapeutics, Inc. completed the acquisition of Big Cypress Acquisition Corp. in a reverse merger transaction.	21-10-21	CI
BIG CYPRESS ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	21-10-21	AQ
Big Cypress Acquisition Corp. Announces Board Changes	21-10-21	CI
Big Cypress Acquisition Corp. : Stockholders Approve Business Combination with SAB Biotherapeutics	21-10-21	PR
SAB Corporate Presentation	21-10-14	PU
BIG CYPRESS ACQUISITION CORP. : Other Events (form 8-K)	21-10-13	AQ
R&D Day Presentation	21-10-12	PU
BIG CYPRESS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	21-10-12	AQ
Big Cypress Acquisition : SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021	21-10-06	BU
Big Cypress Acquisition : SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19	21-10-04	BU
SAB Biotherapeutics : Appoints Russell Beyer Chief Financial Officer	21-09-28	BU
SAB Biotherapeutics : Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19	21-09-24	BU
Big Cypress Acquisition Corp : Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics	21-09-23	PR
Big Cypress Acquisition : SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19	21-09-22	BU
SAB Biotherapeutics : Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza	21-09-15	BU
SAB Biotherapeutics : to Present at Upcoming September Virtual Investor Conferences	21-09-08	BU
Big Cypress Acquisition : FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Form 8-K)	21-08-16	PU
BIG CYPRESS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-08-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Big Cypress Acquisition Corp. Nasdaq

Equities

BCYPU

US0891152086

All News

Filters